FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

4074501000001101: Report only serious adverse reactions to the Committee on Safety of Medicines (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
10072401000001114 Report only serious adverse reactions to the Committee on Safety of Medicines en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36829401000001111 Report only serious adverse reactions to the Committee on Safety of Medicines (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Report only serious adverse reactions to the Committee on Safety of Medicines Is a CSM warning status messages true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Epilim 200mg/5mL s/f liquid CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Epilim 500mg e/c tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Epilim 200mg e/c tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Epilim 100mg crushable tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Primidone 250mg/5mL oral suspension CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Primidone 250mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mysoline 250mg/5mL oral suspension CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mysoline 250mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Phenytoin sodium 100mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ethosuximide 250mg/5mL oral solution - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ethosuximide 250mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zarontin 250mg/5mL syrup CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zarontin 250mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Emeside 250mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Clonazepam 2mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Clonazepam 500micrograms tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbamazepine 400mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbamazepine 200mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbagen SR 400mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Carbagen SR 200mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Teril Retard 400mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Teril Retard 200mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Timonil Retard 400mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Timonil Retard 200mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tegretol 250mg suppository CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tegretol 125mg suppository CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Epimaz 400mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Epimaz 200mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Epimaz 100mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tegretol Retard 400mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tegretol Retard 200mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Tegretol 100mg/5mL oral liquid CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sanomigran 250micrograms/5mL elixir CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sanomigran 500micrograms tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Methysergide 1mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Deseril 1mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Clonidine hydrochloride 25micrograms tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dixarit 25mcg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Maxalt Melt 10mg wafer CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Maxalt 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Maxalt 5mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Rizatriptan 10mg wafer - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Rizatriptan 10mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Rizatriptan 5mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Naramig 2.5mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Naratriptan 2.5mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zomig 5mg nasal spray CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zolmitriptan 5mg nasal spray - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zomig Rapimelt 2.5mg oro-dispersible tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zolmitriptan 2.5mg oro-dispersible tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zomig 2.5mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zolmitriptan 2.5mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Imigran 20mg nasal spray CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Convulex 500mg e/c capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Convulex 300mg e/c capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Convulex 150mg e/c capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Piracetam 333.3mg/1mL oral solution - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Piracetam 1.2g tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Piracetam 800mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nootropil 333.1mg/mL solution CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nootropil 1.2g tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nootropil 800mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamotrigine 2mg dispersible tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamictal 200mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamotrigine 100mg dispersible tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamotrigine 25mg dispersible tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamotrigine 5mg dispersible tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamictal 100mg dispersible tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamictal 25mg dispersible tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamictal 5mg dispersible tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamictal 25mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamotrigine 25mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamictal 100mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamictal 50mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamotrigine 100mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lamotrigine 50mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sabril 500mg/sachet powder CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Vigabatrin 500mg/sachet powder - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sabril 500mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Vigabatrin 500mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sodium valproate 200mg/5mL syrup - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sodium valproate 200mg/5mL s/f oral liquid - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sodium valproate 100mg crushable tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sodium valproate 400mg injection+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sodium valproate 500mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sodium valproate 300mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sodium valproate 200mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Epilim Chrono 500 m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Epilim Chrono 300 m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Epilim Chrono 200 m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Orlept 500mg e/c tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Orlept 200mg e/c tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Epival CR 500mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Epival CR 300mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Orlept 200mg/5mL s/f liquid CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sodium valproate 500mg e/c tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sumatriptan 20mg nasal spray - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sumatriptan 6mg/0.5mL injection refill - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sumatriptan 50mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Imigran 50mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Imigran Subject 6mg/0.5mL injection refill CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier

Start Previous Page 73 of 118 Next End

This concept is not in any reference sets

Back to Start